Resolve Biosciences provides Molecular Cartography™, a multi-modal spatial profiling platform designed for advanced tissue analysis. The technology enables true single-molecule RNA fluorescence in situ hybridization without clearing or signal amplification, allowing simultaneous profiling of RNA, protein, and morphology on the same tissue section. By leveraging artificial intelligence, the platform advances spatial biology and precision medicine. It helps users characterize tissue architecture, investigate disease pathology, and translate insights into clinical relevance for solid tumors, improving patient stratification through spatially-resolved biomarker identification.